Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chevret

Showing results (31-40 of 226) with videos related to

Pageof 23
Sort By:
Revue Des Maladies Respiratoires|August 11, 2005
[Survival analysis: how to manage censored data? The Kaplan-Meier's méthod]C Alberti, J F Timsit, S Chevret
Statistics in Medicine|March 12, 2011
Dose-finding design driven by efficacy in onco-hematology phase I/II trialsV Seegers, S Chevret, M Resche-Rigon
Statistics in Medicine|July 17, 1999
Visit-driven endpoints in randomized HIV/AIDS clinical trials: impact of missing data on treatment difference measured on summary statisticsE Le Corfec, S Chevret, D Costagliola
Revue Des Maladies Respiratoires|August 5, 2004
[Contingency tables and the chi2]J-F Timsit, S Chevret, C Alberti
Blood|August 21, 2001
Alternate designs for conduct and analysis of phase I cancer trialsV Lévy, S Zohar, R Porcher, et al.
Statistics in Medicine|June 7, 2006
Misspecified regression model for the subdistribution hazard of a competing riskA Latouche, V Boisson, S Chevret, et al.
Intensive Care Medicine|January 1, 1993
Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial PneumoniaS Chevret, M Hemmer, J Carlet, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1997
[Delay in diagnosing melanoma. A prospective study in 102 patients]M Baccard, S Chevret, P Chemaly, et al.
Critical Care Medicine|June 25, 2002
Toward an ethical consultation in intensive care?F Pochard, E Azoulay, S Chevret, et al.
Methods of Information in Medicine|September 26, 2015
A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival OutcomesM Moatti, S Chevret, S Zohar, et al.
Pageof 23

Showing results (31-40 of 226) with videos related to

Sort By:
Pageof 23
Revue Des Maladies Respiratoires|August 11, 2005
[Survival analysis: how to manage censored data? The Kaplan-Meier's méthod]C Alberti, J F Timsit, S Chevret
Statistics in Medicine|March 12, 2011
Dose-finding design driven by efficacy in onco-hematology phase I/II trialsV Seegers, S Chevret, M Resche-Rigon
Statistics in Medicine|July 17, 1999
Visit-driven endpoints in randomized HIV/AIDS clinical trials: impact of missing data on treatment difference measured on summary statisticsE Le Corfec, S Chevret, D Costagliola
Revue Des Maladies Respiratoires|August 5, 2004
[Contingency tables and the chi2]J-F Timsit, S Chevret, C Alberti
Blood|August 21, 2001
Alternate designs for conduct and analysis of phase I cancer trialsV Lévy, S Zohar, R Porcher, et al.
Statistics in Medicine|June 7, 2006
Misspecified regression model for the subdistribution hazard of a competing riskA Latouche, V Boisson, S Chevret, et al.
Intensive Care Medicine|January 1, 1993
Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial PneumoniaS Chevret, M Hemmer, J Carlet, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1997
[Delay in diagnosing melanoma. A prospective study in 102 patients]M Baccard, S Chevret, P Chemaly, et al.
Critical Care Medicine|June 25, 2002
Toward an ethical consultation in intensive care?F Pochard, E Azoulay, S Chevret, et al.
Methods of Information in Medicine|September 26, 2015
A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival OutcomesM Moatti, S Chevret, S Zohar, et al.
Pageof 23